clindamycin

Pharmacology
Kinetic Driver of Antibacterial Drugs against Plasmodium falciparum and Implications for Clinical Dosing
Antibacterial drugs are an important component of malaria therapy. We studied the interactions of clindamycin, tetracycline, chloramphenicol, and ciprofloxacin against Plasmodium falciparum under static and dynamic conditions. In microtiter plate assays (static conditions), and as expected, parasites displayed the delayed death response characteristic for apicoplast-...

Emily Caton, Elizabeth Nenortas, Rahul P. Bakshi, Theresa A. Shapiro
Clinical Therapeutics
Treating Anthrax-Induced Meningitis in Rabbits
Amir Ben-Shmuel, Itai Glinert, Assa Sittner, Elad Bar-David, Josef Schlomovitz, Tal Brosh, David Kobiler, Shay Weiss, Haim Levy
Pharmacology
Pharmacokinetics of Clindamycin in Obese and Nonobese Children
Michael J. Smith, Daniel Gonzalez, Jennifer L. Goldman, Ram Yogev, Janice E. Sullivan, Michael D. Reed, Ravinder Anand, Karen Martz, Katherine Berezny, Daniel K. Benjamin, P. Brian Smith, Michael Cohen-Wolkowiez, Kevin Watt
and on behalf of the Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee
Letter to the Editor
Reply to “Modulatory Effects of a Subinhibitory Concentration of Clindamycin in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains of Sequence Type 30”
Katrin Schilcher, Vanina Dengler Haunreiter, Annelies S. Zinkernagel
Letter to the Editor
Modulatory Effects of a Subinhibitory Concentration of Clindamycin in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains of Sequence Type 30
Chris K. Y. Wong, Lin Zheng, Margaret Ip
Mechanisms of Resistance
Macrolide and Clindamycin Resistance in Streptococcus milleri Group Isolates from the Airways of Cystic Fibrosis Patients
Margot E. Grinwis, Christopher D. Sibley, Michael D. Parkins, Christina S. Eshaghurshan, Harvey R. Rabin, Michael G. Surette
Pharmacology
Pharmacokinetics of Clindamycin in Pregnant Women in the Peripartum Period
Anouk E. Muller, Johan W. Mouton, Paul M. Oostvogel, P. Joep Dörr, Rob A. Voskuyl, Joost DeJongh, Eric A. P. Steegers, Meindert Danhof
Susceptibility
In Vitro Activity of Mirincamycin (U24729A) against Plasmodium falciparum Isolates from Gabon
Jana Held, Richard Westerman, Peter G. Kremsner, Benjamin Mordmüller
Clinical Therapeutics
Continuous Clindamycin Infusion, an Innovative Approach to Treating Bone and Joint Infections
Valérie Zeller, Arnaud Dzeing-Ella, Marie-Dominique Kitzis, Jean-Marc Ziza, Patrick Mamoudy, Nicole Desplaces
Mechanisms of Action: Physiological Effects
Clindamycin-Induced CovS-Mediated Regulation of the Production of Virulent Exoproteins Streptolysin O, NAD Glycohydrolase, and Streptokinase in Streptococcus pyogenes
Masaaki Minami, Takuya Kamimura, Masanori Isaka, Ichiro Tatsuno, Michio Ohta, Tadao Hasegawa

Main menu

User menu

Search

clindamycin

Pages